NEW YORK, Jan. 8, 2026 /PRNewswire/ -- Klotho Neurosciences, Inc. (Nasdaq: KLTO, "Klotho", or "the Company"), a U.S.-based biogenetics company, announces that CEO Dr. Joseph Sinkule will be presenting ...
For the fastest way to join Tom's Guide Club enter your email below. We'll send you a confirmation and sign you up to our newsletter to keep you updated on all the latest news. By submitting your ...
Don't miss the big stories. Like us on Facebook. NEW YORK, Nov. 7, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO ) (the "Company" or "Klotho"), a U.S.-based biogenetics company, ...
NEW YORK, Nov. 7, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO ) (the "Company" or "Klotho"), a U.S.-based biogenetics company, announces it has been selected as winner of the Fifth ...
For the fastest way to join Tom's Guide Club enter your email below. We'll send you a confirmation and sign you up to our newsletter to keep you updated on all the latest news. By submitting your ...
Matt Nelson is an automotive journalist with nearly a decade of experience in all things cars. He's spent years working at dealerships in sales, finance, and service. He's since traded in his pens and ...
Jacqueline Joy Battjes’ commitment to functional and regenerative medicine aligns perfectly with our mission to deliver effective, patient-focused care.” — Trace Herchman, President of GetHairMD ...
BAKU, Azerbaijan, September 25. Construction work on Baku Metro’s B4 station is scheduled to be completed by the end of 2026, said Mammad Rzayev, Deputy Head of the Construction Project Management ...
Patients gain access to AI-powered analysis, DNA-based protocols, and non-invasive treatments with 90%+ success rates Jacqueline Joy Battjes' commitment to functional and regenerative medicine aligns ...
Shares of the anti-aging biogenetics company Klotho Neurosciences, Inc. (NASDAQ:KLTO) are on retail investors' radars after the stock exploded by more than 500% in June. Here's a look at recent ...
Shares of Klotho Neurosciences Inc (NASDAQ:KLTO) skyrocketed over 680% to $1.60 during Monday morning trading after the company highlighted promising pre-clinical study findings for its anti-aging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results